DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses

Vaccine

Volumn 17, Issue 5, 1999, Pages 473-479

  Hwee Leeeach Of These Authors Equally Contributed , Ann ^a   Suk Suh, You ^a   Chul Sung, Young ^a  

^a Department of Chemistry   (South Korea)

Author keywords

Cytokine genes; DNA inoculation; HIV 1

Indexed keywords

CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS GENOME;

AIDS VACCINES; ANIMALS; COS CELLS; CYTOKINES; FEMALE; GENES, VIRAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HELA CELLS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; PLASMIDS; RATS; RATS, INBRED BUF; T-LYMPHOCYTES; VACCINES, DNA; VIRAL STRUCTURAL PROTEINS;

EID: 0345490897     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00221-7     Document Type: Article

References (29)

1. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L.et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med. 3:1997;526-532.
2. Hinkula J., Svanholm C., Schwartz S., Lundholm P., Brytting M.et al. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol. 71:1997;5528-5539.
3. Shiver J.W., Davies M.E., Perry H.C., Freed D.C., Liu M.A. Humoral and cellular immunities elicited by HIV-1 vaccination. J Pharm Sci. 85:1996;1317-1324.
4. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K.et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
5. Cuisinier A.M., Mallet V., Meyer A., Caldora C., Aubert A. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus. Vaccine. 15:1997;1085-1094.
6. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F.et al. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol. 70:1996;3978-3991.
7. Richardson J., Moraillon A., Baud S., Cuisinier A.M., Sonigo P., Pancino G. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol. 71:1997;9640-9649.
8. Okuda K., Bukawa H., Hamajima K., Kawamoto S., Sekigawa K., Yamada Y., Tanaka S., Ishi N., Aoki I., Nakamura M. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retroviruses. 11:1995;933-943.
9. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., Robinson H.L. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology. 209:1995;147-154.
10. Tsuji T., Hamajima K., Fukushima J., Xin K.Q., Ishii N.et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol. 158:1997;4008-4013.
11. Xiang Z., Ertl H.C. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135.
12. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol. 71:1997;169-178.
13. Sin J.I., Sung J.H., Suh Y.S., Lee A.H., Chung J.H., Sung Y.C. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene. Vaccine. 15:1997;1827-1833.
14. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol. 158:1997;4591-4601.
15. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 158:1997;816-826.
16. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF) expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol. 159:1997;3638-3647.
17. Collette Y., Chang H.L., Cerdan C., Chambost H., Algarte M., Mavas C., Imbert J., Burny A., Olive D. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. J Immnol. 156:1998;360-370.
18. Lindemann D., Wilhelm R., Renard P., Althage A., Zinkernagel R., Mous J. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3′-long terminal repeat transgene. J Exp Med. 179:1994;797-807.
19. Skowronski J., Parks D., Mariani R. Altered T cell activation development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:1993;703-713.
20. Viscidi R.P., Mayur K., Lederman H.M., Frankel A.D. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science. 246:1989;1606-1608.
21. Xiang Z.Q., He Z., Wang Y., Ertl H.C. The effect of interferon-gamma on genetic immunization. Vaccine. 15:1997;896-898.
22. Terwilliger E.F., Godin B., Sodroski J., Haseltine W.A. Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc Natl Acad Sci USA. 86:1989;3857-3861.
23. Sodroski J., Goh W.C., Rosen C., Tartar A., Portetelle D., Burny A., Haseltine W. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science. 231:1986;1549-1553.
24. Lee A.H., Suh Y.S., Sung J.H., Yang S.H., Sung Y.C. Comparison various expression plasmids for the induction of immune response by DNA immunization. Mol Cells. 7:1997;495-501.
25. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H.et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA. 90:1993;3539-3543.
26. Quillent C., Borman A.M., Paulous S., Dauguet C., Clavel F. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology. 219:1996;29-36.
27. Hart C.E., Ou C.Y., Galphin J.C., Moore J., Bacheler L.T.et al. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science. 246:1989;488-491.
28. Trono D., Baltimore D. A human cell factor is essential for HIV-1 Rev action. EMBO J. 9:1990;4155-4160.
29. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E.et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control, of viremia. Science. 278:1997;1447-1450.